ERBB2 and neoplasm: In a murine bladder tumor model, the combination of FOXO3 shRNA and the Her2/neu DNA vaccine significantly enhanced CD8+ T cell-dependent cytotoxic activity and the anti-tumor effect in a murine tumor model [81].